Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology..

Lipid accumulation and inflammatory response are two major risk factors for atherosclerosis. Baicalein, a phenolic flavonoid widely used in East Asian countries, possesses a potential atheroprotective activity. However, the underlying mechanisms remain elusive. This study was performed to explore the impact of baicalein on lipid accumulation and inflammatory response in THP-1 macrophage-derived foam cells. Our results showed that baicalein up-regulated the expression of ATP binding cassette transporter A1 (ABCA1), ABCG1, liver X receptor α (LXRα), and peroxisome proliferator-activated receptor γ (PPARγ), promoted cholesterol efflux, and inhibited lipid accumulation. Administration of baicalein also reduced the expression and secretion of TNF-α, IL-1β, and IL-6. Knockdown of LXRα or PPARγ with siRNAs abrogated the effects of baicalein on ABCA1 and ABCG1 expression, cholesterol efflux, lipid accumulation as well as pro-inflammatory cytokine release. In summary, these findings suggest that baicalein exerts a beneficial effect on macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα signaling pathway.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:209

Enthalten in:

Clinical and experimental immunology - 209(2022), 3 vom: 29. Sept., Seite 316-325

Sprache:

Englisch

Beteiligte Personen:

Zhang, Zi-Zhen [VerfasserIn]
Yu, Xiao-Hua [VerfasserIn]
Tan, Wei-Hua [VerfasserIn]

Links:

Volltext

Themen:

49QAH60606
97C5T2UQ7J
Baicalein
Cholesterol
Flavanones
Flavonoids
Inflammatory response
Interleukin-6
Journal Article
LXRα
Lipid accumulation
Liver X Receptors
PPARγ
PPAR gamma
Research Support, Non-U.S. Gov't
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 03.10.2022

Date Revised 01.07.2023

published: Print

Citation Status MEDLINE

doi:

10.1093/cei/uxac062

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM342703633